APN-1125
- Generic Name
- APN-1125
Safety, Tolerability, and Pharmacokinetics of APN1125 in Subjects With Schizophrenia
- First Posted Date
- 2016-03-31
- Last Posted Date
- 2016-07-13
- Lead Sponsor
- CoMentis
- Target Recruit Count
- 30
- Registration Number
- NCT02724917
- Locations
- 🇺🇸
Collaborative Neuroscience Network, Long Beach, California, United States
Safety, Tolerability, and Pharmacokinetics of Single Doses of APN1125 in Healthy Normal Subjects
- First Posted Date
- 2015-01-06
- Last Posted Date
- 2016-04-08
- Lead Sponsor
- CoMentis
- Target Recruit Count
- 58
- Registration Number
- NCT02331433
- Locations
- 🇺🇸
PAREXEL Early Phase, Glendale, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath